Britain continues to invest heavily in science, but investment alone will not secure long-term economic growth. The real challenge is creating the conditions for British discoveries and science businesses to scale, manufacture and remain in Britain.
Britain has world-class universities and research institutions, and a strong record of investing in national scientific infrastructure. From Diamond Light Source and the Catapult network to quantum technologies and satellite testing, that ambition is clear.
The commitment remains strong. Government plans provide £58.5 billion of Department for Science, Innovation and Technology (DSIT) research and development (R&D) investment between 2026/27 and 2029/30, with public investment intended to stimulate significantly greater private-sector R&D.
Following the Budget, however, the question should not simply be whether the Government is investing enough in science. It should be whether Britain has the economic conditions to turn that science into long-term economic value.
Five areas will determine whether the Budget helps achieve this.
- Protecting the foundations of innovation
Universities are sometimes viewed primarily through the lens of education policy. That dramatically underestimates their economic importance.
Universities are fundamental to Britain’s science economy. They generate research and intellectual property, educate scientists and engineers, create spinouts, attract international talent and anchor many of our most successful science clusters.
The Government’s continued commitment to research is therefore welcome. UK Research and Innovation’s (UKRI) 2026 budget allocations show funding increasing towards £10 billion annually by 2030, supporting fundamental research alongside strategic priorities and innovative companies.
But headline R&D figures tell only part of the story. The financial health of the universities producing much of that research is critical to Britain’s ability to sustain its science economy. Damage that foundation today and the consequences may not become fully visible for years, by which point rebuilding lost capability will be much harder and more expensive.
- Making Britain attractive to investors
Science is capital hungry.
Businesses in biotechnology, quantum technologies, semiconductors, advanced materials and other deep-tech sectors can require years of patient capital and specialist facilities before producing significant commercial returns.
Tax policy is therefore also science policy.
Investors must weigh substantial technical risk and long investment periods against potential returns. Capital is international. A British science company seeking a significant funding round is competing for investment against opportunities in Boston, California, Singapore and across Europe.
Britain must be careful that measures intended to raise tax revenue do not inadvertently make it less attractive to the long-term investors its science economy needs.
A practical test of any Budget measure should be simple:
Does this make an investor more or less likely to provide the long-term capital needed to scale a British science company in Britain?
- Closing the scale-up gap
Britain is exceptionally good at invention and increasingly successful at creating companies around it. The challenge is what happens next. UKRI’s 2026 budget allocations identify supporting innovative companies to start and scale as a major investment priority.
Funding programmes alone, however, will not solve the problem. Businesses need to be able to progress through the full innovation journey:
University research → spinout → incubator → scale-up → pilot production → commercial manufacturing
Too often, Britain succeeds at the early stages of this journey, only for later investment, manufacturing, employment and company value to migrate elsewhere.
The success of Britain’s science strategy should not be measured simply by how many businesses we start. It should increasingly be measured by how many we successfully grow and retain.
- Investing in infrastructure science
One area where Britain should have considerable confidence is ‘infrastructure science’: major shared scientific facilities and capabilities that would be difficult for individual businesses to create economically, but which strengthen the wider science ecosystem.
Diamond Light Source is an obvious example. Others include investment in quantum technologies, advanced computing, satellite testing and the Catapult network.
These facilities do much more than support individual research projects. They attract talent and businesses, create supply chains, develop specialist expertise and establish ecosystems around emerging technologies.
Britain should continue to make these investments, but building world-class research infrastructure cannot be the end of the strategy. It needs to be the beginning.
Britain can fund the research, build the facility, develop the intellectual property and create the start-up. But without the right conditions for growth, another country may ultimately capture the investment, manufacturing, jobs and long-term economic value.
- Creating somewhere science businesses can grow
One issue receives less attention in Budget commentary, but it is becoming increasingly important.
As science companies scale, many need increasingly specialised buildings and infrastructure.
A successful company may progress from a university laboratory to an incubator, commercial laboratory, pilot plant, demonstration facility and, ultimately, full-scale manufacturing.
At each stage, its infrastructure requirements become more demanding. Companies may need cleanrooms, specialist ventilation, high-purity utilities, significant electrical capacity, cooling and process infrastructure. Delivering these facilities depends on appropriately serviced buildings, reliable power and planning certainty.
The distinction between science and advanced manufacturing is becoming increasingly blurred. Planning, grid capacity, energy infrastructure, skills and suitable industrial property must therefore form part of Britain’s science strategy.
Investment in technology and private capital will not deliver its full economic value if a company cannot secure power, suitable buildings or infrastructure when it is ready to build a pilot plant or manufacturing facility.
The physical infrastructure must support each stage of growth:
Research laboratory → scale-up space → pilot plant → manufacturing
This has practical consequences for science companies, universities, developers and investors. Power availability, planning certainty, servicing requirements and a building’s adaptability should be considered early rather than treated as problems to solve once a business is ready to expand.
Author: Andrew Somerville, Partner, Cundall